Ocular Proteomics Information

View Top Employees from Ocular Proteomics

Closed for business as of 2016. Ocular Proteomics was a research and development company focused on discovery, development and commercialization of biomarkers as a method of improving our understanding of ocular diseases on a molecular level. The company’s primary research tool centers on Reverse Phase Protein Microarrays (RPMAs) to analyze longitudinal samples of vitreous humor from patients in key disease demographics, which includes Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR).

Website	https://ocularproteomics.com
Revenue	$5.4 million
Employees	1 (0 on RocketReach)
Founded	2008
Address	800 W Baltimore St, Baltimore, Maryland 21201, US
Phone	+1 410-244-5528
Technologies	JavaScript , Nginx , jQuery +4 more (view full list)
Industry	Research Services, Business Services General, Biotechnology, Proteomics research, Business Services, Other Pharmaceuticals and Biotechnology, Ocular disease proteome mapping, Macular degeneration research, Diabetic retinopathy research
Keywords	Ophthalmic Diagnostics, Ocular Therapeutics, Eye Disease Research, Eye Disease Diagnostics
Competitors	Proteomics International, SomaLogic, Biognosys, Thermo Fisher Scientific, Waters Corporation, Agilent Technologies, Genomatix AG, MilliporeSigma, Oxford Nanopore Technologies, Bruker +33 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies